In the clinics, expression of pro-apoptotic Bax has been associated with increased survival in advanced CRC patients33, 34 while reduced Bax:Bcl2 ratio was correlated with age and tumor location in CRC patients35. The gene discussed is BCL2; the disease is colorectal carcinoma.